An existing anti-stroke drug is an effective treatment for middle-ear infections, showing the ability to suppress mucus overproduction, improve bacterial clearance and reduce hearing loss, according to researchers at Georgia State Univ. and the Univ. of Rochester. The findings could result in a novel, non-antibiotic treatment for otitis media, or middle-ear infection, possibly through topical drug delivery.
The number of new Ebola cases is tapering off, but the search for new treatments continues. Now...
A class of FDA-approved cancer drugs may be able to prevent problems with brain cell development...
Nanoengineers at the Univ. of California, San Diego developed a gel filled with toxin-absorbing nanosponges that could lead to an effective treatment for skin and wound infections caused by MRSA, an antibiotic-resistant bacteria. This "nanosponge-hydrogel" minimized the growth of skin lesions on mice infected with MRSA, without the use of antibiotics.
Researchers have discovered the structure of a key protein on the surface of an unusually large virus called the mimivirus, aiding efforts to determine its hosts and unknown functions. The mimivirus was initially thought to be a bacterium because it is much larger than most viruses. It was isolated by French scientists in 1992 but wasn't confirmed to be a virus until 2003.
With the arrival of spring, millions of people have begun their annual ritual of sneezing and wheezing due to seasonal allergies. A research team is bringing people hope with a potential vaccine that nudges the immune response away from developing allergies. The findings have clinical implications since allergies and asthma are lifelong conditions that often start in childhood and for which there is presently no cure.
A new target for drug development in the fight against the deadly disease malaria has been discovered by researchers at Massachusetts Institute of Technology. In a recently published paper, the researchers describe how they identified the drug target while studying the way in which the parasites Toxoplasma gondii, which causes toxoplasmosis, and Plasmodium, which causes malaria, access vital nutrients from their host cells.
A new study led by researchers at the Univ. of Minnesota has found a three-way link among antibiotic use in infants, changes in the gut bacteria and disease later in life. The imbalances in gut microbes, called dysbiosis, have been tied to infectious diseases, allergies and other autoimmune disorders, and obesity later in life.
For the first time, a large study suggests that a vitamin might modestly lower the risk of the most common types of skin cancer in people with a history of these relatively harmless yet troublesome growths. In a study in Australia, people who took a specific type of vitamin B3 for a year had a 23% lower rate of new skin cancers compared to others who took dummy pills.
A potential mechanism to combat diseases caused by haemorrhagic fever viruses has been discovered by researchers at the Univ. of Montreal's Dept. of Biochemistry and Molecular Medicine. These diseases present a dramatic risk to human health as they often spread quickly and kill a high percentage of infected individuals, as demonstrated by the recent Ebola outbreaks.
Therapies that specifically target mutations in a person’s cancer have been much-heralded in recent years, yet cancer cells often find a way around them. To address this, researchers identified a promising combinatorial approach to treating glioblastomas, the most common form of primary brain cancer.
In recent years, public health concerns about post-traumatic stress disorder (PTSD) have risen significantly, driven in part by affected military veterans returning from conflicts in the Middle East and elsewhere. PTSD is associated with number of psychological maladies, among them chronic depression, anger, insomnia, eating disorders and substance abuse.
For the first time, Ebola has been discovered inside the eyes of a patient months after the virus was gone from his blood. The case concerns Dr. Ian Crozier, an American physician who caught Ebola in September while working in West Africa. He was treated at Emory Univ. in Atlanta and released when he was no longer contagious.
Diagnosing a heart attack can require multiple tests using expensive equipment. But not everyone has access to such techniques, especially in remote or low-income areas. Now scientists have developed a simple, thermometer-like device that could help doctors diagnose heart attacks with minimal materials and cost. The report on their approach appears in Analytical Chemistry.
Your employer may one day help determine if your genes are why your jeans have become too snug. Big companies are considering blending genetic testing with coaching on nutrition and exercise to help workers lose weight and improve their health before serious conditions like diabetes or heart disease develop.
One in three Americans has high blood pressure, a long-term constriction of arteries that can lead to coronary heart disease, heart failure and stroke. Using a sophisticated x-ray analysis, a U.S.-German team of scientists revealed the molecular structure of the angiotensin receptor AT1R, an important regulator for blood pressure in the human body.
As baby boomers age, the number of people diagnosed with Parkinson's disease is expected to increase. Patients who develop this disease usually start experiencing symptoms around age 60 or older. Currently, there's no cure, but scientists are reporting a novel approach that reversed Parkinson's-like symptoms in rats. Their results, published in ACS Nano, could one day lead to a new therapy for human patients.
Scientists have determined the 3-D structure of a key part of a protein that is associated with glaucoma and identified regions of this domain that correlate with severe forms of the disease. The new crystal structure is of the olfactomedin (OLF) domain in myocilin, a protein implicated in glaucoma. Many proteins have OLF domains, but mutations in the OLF domain of myocilin are linked to early-onset glaucoma.
As the current Ebola outbreak wanes, scientists have to make the most of every opportunity to prepare for future outbreaks. One such opportunity involves the identification of a safe and effective Ebola vaccine. Texas supercomputers have aided researchers in modeling which types of clinical trials will provide the best information.
A concentrated extract of maple syrup makes disease-causing bacteria more susceptible to antibiotics, according to laboratory experiments by researchers at McGill Univ. The findings suggest that combining maple syrup extract with common antibiotics could increase the microbes’ susceptibility, leading to lower antibiotic usage.
Brain tumors are notoriously difficult for most drugs to reach, but Yale Univ. researchers have found a promising but unlikely new ally against brain cancers, portions of a deadly virus similar to Ebola. A virus containing proteins found in the Lassa virus not only passed through the formidable blood-brain barrier but destroyed brain tumors in mice, according to research released in the Journal of Virology.
Millions of older people are getting tests they don't need to prove they are healthy enough to have cataracts removed, a new study finds. The excess testing before this quick, ultra-safe eye procedure is costing them and Medicare a bundle, and many patients don't know they can question it, doctors say.
A newly developed spectroscopy method is helping to clarify the poorly understood molecular process by which an anti-HIV drug induces lethal mutations in the virus’ genetic material. The findings from the Univ. of Chicago and the Massachusetts Institute of Technology could bolster efforts to develop the next generation of anti-viral treatments.
Opening the door to potential treatments for the deadly Ebola virus, scientists have found that a protein made by the virus plays a role similar to that of a coat-check attendant.
A new collaborative study describes a way that lung tissue can regenerate after injury.
The discovery of antibiotics produced by soil fungi and bacteria gave the world life-saving medicine. But new antimicrobials from this resource have become scarce as the threat of drug resistance grows. Now, scientists have started mining lakes and rivers for potential pathogen-fighters, and they’ve found one from Lake Michigan that is effective against drug-resistant tuberculosis.
Yale Univ. scientists are using new chemical tools to identify and understand molecules in the human gut that alter DNA and regulate inflammatory bowel diseases and colorectal cancers. In a recent article, researchers describe the chemical structures of 32 such molecules from the bacterial colibactin pathway, found in select strains of E. coli in the gut.
Consumers are one step closer to benefiting from packaging that could give simple text warnings when food is contaminated with deadly pathogens like E. coli and Salmonella, and patients could soon receive real-time diagnoses of infections such as C. difficile right in their doctors' offices, saving critical time and trips to the lab.
- Page 1